Renaissance Global Innovation Fund Class F (ATL1645)
34.56
0.00 (0.00%)
CAD |
Jan 15 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.07% | 535.85M | 0.70% | 68.37% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| 40.53M | 19.32% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Information Technology |
| Peer Group | Global Equity |
| Global Macro | -- |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Renaissance Investments |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
27
-269.85M
Peer Group Low
1.187B
Peer Group High
1 Year
% Rank:
19
40.53M
-6.867B
Peer Group Low
4.762B
Peer Group High
3 Months
% Rank:
24
-895.93M
Peer Group Low
1.461B
Peer Group High
3 Years
% Rank:
17
-6.518B
Peer Group Low
8.317B
Peer Group High
6 Months
% Rank:
19
-1.714B
Peer Group Low
2.911B
Peer Group High
5 Years
% Rank:
21
-4.371B
Peer Group Low
9.561B
Peer Group High
YTD
% Rank:
--
-1.899B
Peer Group Low
2.538B
Peer Group High
10 Years
% Rank:
20
-3.791B
Peer Group Low
10.03B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of January 16, 2026.
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 1.11% |
| Stock | 93.96% |
| Bond | 4.95% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.03% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Alphabet, Inc. | 10.66% | 328.87 | -1.17% |
| NVIDIA Corp. | 8.79% | 187.77 | 0.38% |
| Apple, Inc. | 7.70% | 255.20 | -1.17% |
| Microsoft Corp. | 6.62% | 461.35 | 1.03% |
| Eli Lilly & Co. | 5.97% | 1049.27 | 1.58% |
| Roche Holding AG | 4.73% | 439.16 | -0.52% |
| Meta Platforms, Inc. | 4.40% | 625.58 | 0.77% |
| Novartis AG | 4.18% | 140.22 | -4.67% |
| Thermo Fisher Scientific, Inc. | 3.76% | 623.13 | -0.24% |
| Broadcom Inc. | 3.73% | 344.79 | 0.52% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | -- |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP |
|
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 500.00 None |
| Minimum Subsequent Investment | 50.00 None |
Basic Info
| Investment Strategy | |
| To obtain long-term capital appreciation by investing in a diversified portfolio of global companies involved mainly in telecommunications, biotechnology, computer hardware and software, and medical services and other scientific and technology based companies. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Large Cap Growth |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Information Technology |
| Peer Group | Global Equity |
| Global Macro | -- |
| US Macro | -- |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Renaissance Investments |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (1-15-26) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 10 |
| Stock | |
| Weighted Average PE Ratio | 38.28 |
| Weighted Average Price to Sales Ratio | 11.82 |
| Weighted Average Price to Book Ratio | 13.89 |
| Weighted Median ROE | 52.78% |
| Weighted Median ROA | 21.00% |
| ROI (TTM) | 28.29% |
| Return on Investment (TTM) | 28.29% |
| Earning Yield | 0.0296 |
| LT Debt / Shareholders Equity | 0.9871 |
| Number of Equity Holdings | 10 |
| Bond | |
| Yield to Maturity (11-30-25) | -- |
| Effective Duration | -- |
| Average Coupon | -- |
| Calculated Average Quality | -- |
| Effective Maturity | -- |
| Nominal Maturity | -- |
| Number of Bond Holdings | 0 |
As of November 30, 2025
Growth Metrics
| EPS Growth (1Y) | 28.83% |
| EPS Growth (3Y) | 15.20% |
| EPS Growth (5Y) | 23.40% |
| Sales Growth (1Y) | 21.82% |
| Sales Growth (3Y) | 15.22% |
| Sales Growth (5Y) | 17.60% |
| Sales per Share Growth (1Y) | 23.40% |
| Sales per Share Growth (3Y) | 16.07% |
| Operating Cash Flow - Growth Rate (3Y) | 19.32% |
As of November 30, 2025
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:ATL1645.TO", "name") |
| Broad Asset Class: =YCI("M:ATL1645.TO", "broad_asset_class") |
| Broad Category: =YCI("M:ATL1645.TO", "broad_category_group") |
| Prospectus Objective: =YCI("M:ATL1645.TO", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |